On October 27, 2023, Helix BioPharma Corp. closed the transaction. In connection with the closing, the company paid a cash fee of 10% of gross proceeds raised to an eligible finder.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.21 CAD | -8.70% | -4.55% | 0.00% |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
0.00% | 35.3M | |
+29.03% | 49.18B | |
-0.10% | 42.11B | |
+49.73% | 40.37B | |
-5.26% | 28.85B | |
+11.48% | 26.09B | |
-22.74% | 18.71B | |
+9.06% | 13.26B | |
+30.01% | 12.32B | |
-1.51% | 11.99B |
- Stock Market
- Equities
- HBP Stock
- News Helix BioPharma Corp.
- Helix BioPharma Corp. announced that it has received CAD 2.998 million in funding